At the news
? NEUTRALIMPACT 2/10 144 filed Oct 26, 2026 at 09:46 ET
Director Gary M. Pfeiffer filed a Form 144 notice of intent to sell 1,203 shares of Quest Diagnostics common stock, valued at approximately $292,329 based on the filing. The shares were acquired through restricted stock vesting on May 15, 2026, and the sale is planned for the NYSE. This is a small, routine sale by a director relative to the company's $26.9B market cap.
- Director Gary M. Pfeiffer filed Form 144 to sell 1,203 shares of Quest Diagnostics common stock.
- The approximate market value of the proposed sale is $292,329.
- Shares were acquired via restricted stock vesting on May 15, 2026, as compensation.
- The sale is planned for execution on the NYSE on October 26, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access